Global Pediatric Medicines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 90139
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Pediatric Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pediatric Medicines size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Pediatric Medicines market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Pediatric Medicines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Enteral

Parenteral

Topical

Market segment by Application can be divided into

Hospital

Clinic

Family

The key market players for global Pediatric Medicines market are listed below:

GSK

Novartis

Pfizer

Sanofi

Abbott

Bristol-Myers Squibb

Cipla

Eisai Pharmaceuticals

Eli Lilly

F. Hoffman-La Roche

Glenmark

Helsinn Healthcare

Heron Therapeutics

Ipca Laboratories

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Pediatric Medicines product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Pediatric Medicines, with price, sales, revenue and global market share of Pediatric Medicines from 2019 to 2021.

Chapter 3, the Pediatric Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pediatric Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pediatric Medicines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Pediatric Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Pediatric Medicines Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Pediatric Medicines Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Enteral

1.2.3 Parenteral

1.2.4 Topical

1.3 Market Analysis by Application

1.3.1 Overview: Global Pediatric Medicines Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Family

1.4 Global Pediatric Medicines Market Size & Forecast

1.4.1 Global Pediatric Medicines Sales in Value (2016-2026))

1.4.2 Global Pediatric Medicines Sales in Volume (2016-2026)

1.4.3 Global Pediatric Medicines Price by Type (2016-2026) & (USD/Unit)

1.5 Global Pediatric Medicines Production Capacity Analysis

1.5.1 Global Pediatric Medicines Total Production Capacity (2016-2026)

1.5.2 Global Pediatric Medicines Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Pediatric Medicines Market Drivers

1.6.2 Pediatric Medicines Market Restraints

1.6.3 Pediatric Medicines Trends Analysis

2 Manufacturers Profiles

2.1 GSK

2.1.1 GSK Details

2.1.2 GSK Major Business

2.1.3 GSK Pediatric Medicines Product and Services

2.1.4 GSK Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Pediatric Medicines Product and Services

2.2.4 Novartis Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Pediatric Medicines Product and Services

2.3.4 Pfizer Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Sanofi

2.4.1 Sanofi Details

2.4.2 Sanofi Major Business

2.4.3 Sanofi Pediatric Medicines Product and Services

2.4.4 Sanofi Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Abbott

2.5.1 Abbott Details

2.5.2 Abbott Major Business

2.5.3 Abbott Pediatric Medicines Product and Services

2.5.4 Abbott Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Bristol-Myers Squibb

2.6.1 Bristol-Myers Squibb Details

2.6.2 Bristol-Myers Squibb Major Business

2.6.3 Bristol-Myers Squibb Pediatric Medicines Product and Services

2.6.4 Bristol-Myers Squibb Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Cipla

2.7.1 Cipla Details

2.7.2 Cipla Major Business

2.7.3 Cipla Pediatric Medicines Product and Services

2.7.4 Cipla Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Eisai Pharmaceuticals

2.8.1 Eisai Pharmaceuticals Details

2.8.2 Eisai Pharmaceuticals Major Business

2.8.3 Eisai Pharmaceuticals Pediatric Medicines Product and Services

2.8.4 Eisai Pharmaceuticals Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Eli Lilly

2.9.1 Eli Lilly Details

2.9.2 Eli Lilly Major Business

2.9.3 Eli Lilly Pediatric Medicines Product and Services

2.9.4 Eli Lilly Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 F. Hoffman-La Roche

2.10.1 F. Hoffman-La Roche Details

2.10.2 F. Hoffman-La Roche Major Business

2.10.3 F. Hoffman-La Roche Pediatric Medicines Product and Services

2.10.4 F. Hoffman-La Roche Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Glenmark

2.11.1 Glenmark Details

2.11.2 Glenmark Major Business

2.11.3 Glenmark Pediatric Medicines Product and Services

2.11.4 Glenmark Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Helsinn Healthcare

2.12.1 Helsinn Healthcare Details

2.12.2 Helsinn Healthcare Major Business

2.12.3 Helsinn Healthcare Pediatric Medicines Product and Services

2.12.4 Helsinn Healthcare Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Heron Therapeutics

2.13.1 Heron Therapeutics Details

2.13.2 Heron Therapeutics Major Business

2.13.3 Heron Therapeutics Pediatric Medicines Product and Services

2.13.4 Heron Therapeutics Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Ipca Laboratories

2.14.1 Ipca Laboratories Details

2.14.2 Ipca Laboratories Major Business

2.14.3 Ipca Laboratories Pediatric Medicines Product and Services

2.14.4 Ipca Laboratories Pediatric Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Pediatric Medicines Sales by Manufacturer

3.1 Global Pediatric Medicines Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Pediatric Medicines Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Pediatric Medicines

3.4 Market Concentration Rate

3.4.1 Top 3 Pediatric Medicines Manufacturer Market Share

3.4.2 Top 6 Pediatric Medicines Manufacturer Market Share

3.5 Global Pediatric Medicines Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Pediatric Medicines Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Pediatric Medicines Market Size by Region

4.1.1 Global Pediatric Medicines Sales in Volume by Region (2016-2026)

4.1.2 Global Pediatric Medicines Revenue by Region (2016-2026)

4.2 North America Pediatric Medicines Revenue (2016-2026)

4.3 Europe Pediatric Medicines Revenue (2016-2026)

4.4 Asia-Pacific Pediatric Medicines Revenue (2016-2026)

4.5 South America Pediatric Medicines Revenue (2016-2026)

4.6 Middle East and Africa Pediatric Medicines Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Pediatric Medicines Sales in Volume by Type (2016-2026)

5.2 Global Pediatric Medicines Revenue by Type (2016-2026)

5.3 Global Pediatric Medicines Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Pediatric Medicines Sales in Volume by Application (2016-2026)

6.2 Global Pediatric Medicines Revenue by Application (2016-2026)

6.3 Global Pediatric Medicines Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Pediatric Medicines Sales by Type (2016-2026)

7.2 North America Pediatric Medicines Sales by Application (2016-2026)

7.3 North America Pediatric Medicines Market Size by Country

7.3.1 North America Pediatric Medicines Sales in Volume by Country (2016-2026)

7.3.2 North America Pediatric Medicines Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Pediatric Medicines Sales by Type (2016-2026)

8.2 Europe Pediatric Medicines Sales by Application (2016-2026)

8.3 Europe Pediatric Medicines Market Size by Country

8.3.1 Europe Pediatric Medicines Sales in Volume by Country (2016-2026)

8.3.2 Europe Pediatric Medicines Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Pediatric Medicines Sales by Type (2016-2026)

9.2 Asia-Pacific Pediatric Medicines Sales by Application (2016-2026)

9.3 Asia-Pacific Pediatric Medicines Market Size by Region

9.3.1 Asia-Pacific Pediatric Medicines Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Pediatric Medicines Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Pediatric Medicines Sales by Type (2016-2026)

10.2 South America Pediatric Medicines Sales by Application (2016-2026)

10.3 South America Pediatric Medicines Market Size by Country

10.3.1 South America Pediatric Medicines Sales in Volume by Country (2016-2026)

10.3.2 South America Pediatric Medicines Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Pediatric Medicines Sales by Type (2016-2026)

11.2 Middle East & Africa Pediatric Medicines Sales by Application (2016-2026)

11.3 Middle East & Africa Pediatric Medicines Market Size by Country

11.3.1 Middle East & Africa Pediatric Medicines Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Pediatric Medicines Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Pediatric Medicines Typical Distributors

12.3 Pediatric Medicines Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Pediatric Medicines Revenue by Type, (USD Million), 2021-2026

Table 2. Global Pediatric Medicines Revenue by Application, (USD Million), 2021-2026

Table 3. GSK Basic Information, Manufacturing Base and Competitors

Table 4. GSK Major Business

Table 5. GSK Pediatric Medicines Product and Services

Table 6. GSK Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Novartis Basic Information, Manufacturing Base and Competitors

Table 8. Novartis Major Business

Table 9. Novartis Pediatric Medicines Product and Services

Table 10. Novartis Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Pfizer Basic Information, Manufacturing Base and Competitors

Table 12. Pfizer Major Business

Table 13. Pfizer Pediatric Medicines Product and Services

Table 14. Pfizer Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Sanofi Basic Information, Manufacturing Base and Competitors

Table 16. Sanofi Major Business

Table 17. Sanofi Pediatric Medicines Product and Services

Table 18. Sanofi Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Abbott Basic Information, Manufacturing Base and Competitors

Table 20. Abbott Major Business

Table 21. Abbott Pediatric Medicines Product and Services

Table 22. Abbott Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table 24. Bristol-Myers Squibb Major Business

Table 25. Bristol-Myers Squibb Pediatric Medicines Product and Services

Table 26. Bristol-Myers Squibb Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Cipla Basic Information, Manufacturing Base and Competitors

Table 28. Cipla Major Business

Table 29. Cipla Pediatric Medicines Product and Services

Table 30. Cipla Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Eisai Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 32. Eisai Pharmaceuticals Major Business

Table 33. Eisai Pharmaceuticals Pediatric Medicines Product and Services

Table 34. Eisai Pharmaceuticals Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 36. Eli Lilly Major Business

Table 37. Eli Lilly Pediatric Medicines Product and Services

Table 38. Eli Lilly Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors

Table 40. F. Hoffman-La Roche Major Business

Table 41. F. Hoffman-La Roche Pediatric Medicines Product and Services

Table 42. F. Hoffman-La Roche Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Glenmark Basic Information, Manufacturing Base and Competitors

Table 44. Glenmark Major Business

Table 45. Glenmark Pediatric Medicines Product and Services

Table 46. Glenmark Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Helsinn Healthcare Basic Information, Manufacturing Base and Competitors

Table 48. Helsinn Healthcare Major Business

Table 49. Helsinn Healthcare Pediatric Medicines Product and Services

Table 50. Helsinn Healthcare Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Heron Therapeutics Basic Information, Manufacturing Base and Competitors

Table 52. Heron Therapeutics Major Business

Table 53. Heron Therapeutics Pediatric Medicines Product and Services

Table 54. Heron Therapeutics Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Ipca Laboratories Basic Information, Manufacturing Base and Competitors

Table 56. Ipca Laboratories Major Business

Table 57. Ipca Laboratories Pediatric Medicines Product and Services

Table 58. Ipca Laboratories Pediatric Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Global Pediatric Medicines Sales by Manufacturer (2019-2021e) & (K Units)

Table 60. Global Pediatric Medicines Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 61. Market Position of Manufacturers in Pediatric Medicines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 62. Global Pediatric Medicines Production Capacity by Company, (K Units): 2020 VS 2021

Table 63. Head Office and Pediatric Medicines Production Site of Key Manufacturer

Table 64. Pediatric Medicines New Entrant and Capacity Expansion Plans

Table 65. Pediatric Medicines Mergers & Acquisitions in the Past Five Years

Table 66. Global Pediatric Medicines Sales by Region (2016-2021e) & (K Units)

Table 67. Global Pediatric Medicines Sales by Region (2021-2026) & (K Units)

Table 68. Global Pediatric Medicines Revenue by Region (2016-2021e) & (USD Million)

Table 69. Global Pediatric Medicines Revenue by Region (2021-2026) & (USD Million)

Table 70. Global Pediatric Medicines Sales by Type (2016-2021e) & (K Units)

Table 71. Global Pediatric Medicines Sales by Type (2021-2026) & (K Units)

Table 72. Global Pediatric Medicines Revenue by Type (2016-2021e) & (USD Million)

Table 73. Global Pediatric Medicines Revenue by Type (2021-2026) & (USD Million)

Table 74. Global Pediatric Medicines Price by Type (2016-2021e) & (USD/Unit)

Table 75. Global Pediatric Medicines Price by Type (2021-2026) & (USD/Unit)

Table 76. Global Pediatric Medicines Sales by Application (2016-2021e) & (K Units)

Table 77. Global Pediatric Medicines Sales by Application (2021-2026) & (K Units)

Table 78. Global Pediatric Medicines Revenue by Application (2016-2021e) & (USD Million)

Table 79. Global Pediatric Medicines Revenue by Application (2021-2026) & (USD Million)

Table 80. Global Pediatric Medicines Price by Application (2016-2021e) & (USD/Unit)

Table 81. Global Pediatric Medicines Price by Application (2021-2026) & (USD/Unit)

Table 82. North America Pediatric Medicines Sales by Country (2016-2021e) & (K Units)

Table 83. North America Pediatric Medicines Sales by Country (2021-2026) & (K Units)

Table 84. North America Pediatric Medicines Revenue by Country (2016-2021e) & (USD Million)

Table 85. North America Pediatric Medicines Revenue by Country (2021-2026) & (USD Million)

Table 86. North America Pediatric Medicines Sales by Type (2016-2021e) & (K Units)

Table 87. North America Pediatric Medicines Sales by Type (2021-2026) & (K Units)

Table 88. North America Pediatric Medicines Sales by Application (2016-2021e) & (K Units)

Table 89. North America Pediatric Medicines Sales by Application (2021-2026) & (K Units)

Table 90. Europe Pediatric Medicines Sales by Country (2016-2021e) & (K Units)

Table 91. Europe Pediatric Medicines Sales by Country (2021-2026) & (K Units)

Table 92. Europe Pediatric Medicines Revenue by Country (2016-2021e) & (USD Million)

Table 93. Europe Pediatric Medicines Revenue by Country (2021-2026) & (USD Million)

Table 94. Europe Pediatric Medicines Sales by Type (2016-2021e) & (K Units)

Table 95. Europe Pediatric Medicines Sales by Type (2021-2026) & (K Units)

Table 96. Europe Pediatric Medicines Sales by Application (2016-2021e) & (K Units)

Table 97. Europe Pediatric Medicines Sales by Application (2021-2026) & (K Units)

Table 98. Asia-Pacific Pediatric Medicines Sales by Region (2016-2021e) & (K Units)

Table 99. Asia-Pacific Pediatric Medicines Sales by Region (2021-2026) & (K Units)

Table 100. Asia-Pacific Pediatric Medicines Revenue by Region (2016-2021e) & (USD Million)

Table 101. Asia-Pacific Pediatric Medicines Revenue by Region (2021-2026) & (USD Million)

Table 102. Asia-Pacific Pediatric Medicines Sales by Type (2016-2021e) & (K Units)

Table 103. Asia-Pacific Pediatric Medicines Sales by Type (2021-2026) & (K Units)

Table 104. Asia-Pacific Pediatric Medicines Sales by Application (2016-2021e) & (K Units)

Table 105. Asia-Pacific Pediatric Medicines Sales by Application (2021-2026) & (K Units)

Table 106. South America Pediatric Medicines Sales by Country (2016-2021e) & (K Units)

Table 107. South America Pediatric Medicines Sales by Country (2021-2026) & (K Units)

Table 108. South America Pediatric Medicines Revenue by Country (2016-2021e) & (USD Million)

Table 109. South America Pediatric Medicines Revenue by Country (2021-2026) & (USD Million)

Table 110. South America Pediatric Medicines Sales by Type (2016-2021e) & (K Units)

Table 111. South America Pediatric Medicines Sales by Type (2021-2026) & (K Units)

Table 112. South America Pediatric Medicines Sales by Application (2016-2021e) & (K Units)

Table 113. South America Pediatric Medicines Sales by Application (2021-2026) & (K Units)

Table 114. Middle East & Africa Pediatric Medicines Sales by Country (2016-2021e) & (K Units)

Table 115. Middle East & Africa Pediatric Medicines Sales by Country (2021-2026) & (K Units)

Table 116. Middle East & Africa Pediatric Medicines Revenue by Country (2016-2021e) & (USD Million)

Table 117. Middle East & Africa Pediatric Medicines Revenue by Country (2021-2026) & (USD Million)

Table 118. Middle East & Africa Pediatric Medicines Sales by Type (2016-2021e) & (K Units)

Table 119. Middle East & Africa Pediatric Medicines Sales by Type (2021-2026) & (K Units)

Table 120. Middle East & Africa Pediatric Medicines Sales by Application (2016-2021e) & (K Units)

Table 121. Middle East & Africa Pediatric Medicines Sales by Application (2021-2026) & (K Units)

Table 122. Direct Channel Pros & Cons

Table 123. Indirect Channel Pros & Cons

Table 124. Pediatric Medicines Typical Distributors

Table 125. Pediatric Medicines Typical Customers

List of Figures

Figure 1. Pediatric Medicines Picture

Figure 2. Global Pediatric Medicines Sales Market Share by Type in 2020

Figure 3. Enteral

Figure 4. Parenteral

Figure 5. Topical

Figure 6. Global Pediatric Medicines Sales Market Share by Application in 2020

Figure 7. Hospital

Figure 8. Clinic

Figure 9. Family

Figure 10. Global Pediatric Medicines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 11. Global Pediatric Medicines Market Size and Forecast (2016-2026) & (USD Million)

Figure 12. Global Pediatric Medicines Sales (2016-2026) & (K Units)

Figure 13. Global Pediatric Medicines Price by Type (2016-2026) & (USD/Unit)

Figure 14. Global Pediatric Medicines Production Capacity (2016-2026) & (K Units)

Figure 15. Global Pediatric Medicines Production Capacity by Geographic Region: 2020 VS 2021

Figure 16. Pediatric Medicines Market Drivers

Figure 17. Pediatric Medicines Market Restraints

Figure 18. Pediatric Medicines Market Trends

Figure 19. Global Pediatric Medicines Sales Market Share by Manufacturer in 2020

Figure 20. Global Pediatric Medicines Revenue Market Share by Manufacturer in 2020

Figure 21. Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. Top 3 Pediatric Medicines Manufacturer (Revenue) Market Share in 2020

Figure 23. Top 6 Pediatric Medicines Manufacturer (Revenue) Market Share in 2020

Figure 24. Global Pediatric Medicines Sales Market Share by Region (2016-2026)

Figure 25. Global Pediatric Medicines Revenue Market Share by Region (2016-2026)

Figure 26. North America Pediatric Medicines Revenue (2016-2026) & (USD Million)

Figure 27. Europe Pediatric Medicines Revenue (2016-2026) & (USD Million)

Figure 28. Asia-Pacific Pediatric Medicines Revenue (2016-2026) & (USD Million)

Figure 29. South America Pediatric Medicines Revenue (2016-2026) & (USD Million)

Figure 30. Middle East & Africa Pediatric Medicines Revenue (2016-2026) & (USD Million)

Figure 31. Global Pediatric Medicines Sales Market Share by Type (2016-2026)

Figure 32. Global Pediatric Medicines Revenue Market Share by Type (2016-2026)

Figure 33. Global Pediatric Medicines Price by Type (2016-2026) & (USD/Unit)

Figure 34. Global Pediatric Medicines Sales Market Share by Application (2016-2026)

Figure 35. Global Pediatric Medicines Revenue Market Share by Application (2016-2026)

Figure 36. Global Pediatric Medicines Price by Application (2016-2026) & (USD/Unit)

Figure 37. North America Pediatric Medicines Sales Market Share by Type (2016-2026)

Figure 38. North America Pediatric Medicines Sales Market Share by Application (2016-2026)

Figure 39. North America Pediatric Medicines Sales Market Share by Country (2016-2026)

Figure 40. North America Pediatric Medicines Revenue Market Share by Country (2016-2026)

Figure 41. United States Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Pediatric Medicines Sales Market Share by Type (2016-2026)

Figure 45. Europe Pediatric Medicines Sales Market Share by Application (2016-2026)

Figure 46. Europe Pediatric Medicines Sales Market Share by Country (2016-2026)

Figure 47. Europe Pediatric Medicines Revenue Market Share by Country (2016-2026)

Figure 48. Germany Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Pediatric Medicines Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Pediatric Medicines Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Pediatric Medicines Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Pediatric Medicines Revenue Market Share by Region (2016-2026)

Figure 57. China Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Korea Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Pediatric Medicines Sales Market Share by Type (2016-2026)

Figure 64. South America Pediatric Medicines Sales Market Share by Application (2016-2026)

Figure 65. South America Pediatric Medicines Sales Market Share by Country (2016-2026)

Figure 66. South America Pediatric Medicines Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East & Africa Pediatric Medicines Sales Market Share by Type (2016-2026)

Figure 70. Middle East & Africa Pediatric Medicines Sales Market Share by Application (2016-2026)

Figure 71. Middle East & Africa Pediatric Medicines Sales Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Pediatric Medicines Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Egypt Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Africa Pediatric Medicines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Sales Channel: Direct Channel vs Indirect Channel

Figure 78. Methodology

Figure 79. Research Process and Data Source